Department of Chemistry, College of Science, Tianjin University, Tianjin 300350, People's Republic of China.
Nanotechnology. 2019 Jun 28;30(26):265102. doi: 10.1088/1361-6528/ab0bd1. Epub 2019 Mar 1.
Synergistic therapy of tumor has attracted the attention of an increasing number of researchers because of its higher efficiency compared to single therapy. Herein, 4-carboxyphenyl porphyrin-conjugated silica-coated gold nanorods (AuNR@SiO-TCPP) were synthesized. The synergistic treatment of photothermal therapy and photodynamic therapy on A549 cancer was researched in vivo and in vitro. In the AuNR@SiO-TCPP, Au NRs and TCPP act as photothermal agent and photosensitizer, respectively. The temperature of the AuNR@SiO-TCPP (0.11 nmol L) rises to 56.8 °C for 10 min under the illumination of 808 nm laser (2 Wcm). In MTT assays, the viability of A549 cancer cell treated with AuNR@SiO-TCPP (100 μg ml) is only 21%. In animal experiments, the relative tumor volumes in mice receiving AuNR@SiO-TCPP (5 mg kg) with 660 and 808 nm irradiations were significantly inhibited and the average value is decreased to 0.78 while the average value of the control group is increased to 7.2. These results demonstrate that the AuNR@SiO-TCPP is a potential nanomedicine against tumor for clinical application in the near future.
由于协同治疗比单一治疗具有更高的效率,因此肿瘤的协同治疗吸引了越来越多的研究人员的关注。本文合成了 4-羧基苯基卟啉偶联二氧化硅包覆的金纳米棒(AuNR@SiO-TCPP)。研究了其在体内和体外对 A549 癌细胞的光热治疗和光动力治疗的协同作用。在 AuNR@SiO-TCPP 中,AuNR 和 TCPP 分别作为光热剂和光敏剂。在 808nm 激光(2Wcm)照射下,AuNR@SiO-TCPP(0.11nmolL)的温度在 10min 内升高到 56.8°C。在 MTT 测定中,用 AuNR@SiO-TCPP(100μgml)处理的 A549 癌细胞的存活率仅为 21%。在动物实验中,接受 AuNR@SiO-TCPP(5mgkg)联合 660nm 和 808nm 照射的小鼠的相对肿瘤体积明显受到抑制,平均值降低至 0.78,而对照组的平均值增加至 7.2。这些结果表明,AuNR@SiO-TCPP 是一种有潜力的肿瘤纳米药物,可在不久的将来用于临床应用。